Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs.
about
Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes.Treatment with the C-C chemokine receptor type 5 (CCR5)-inhibitor maraviroc suppresses growth and induces apoptosis of acute lymphoblastic leukemia cells.The Role of Hypoxia in Glioblastoma Invasion.MCP2 activates NF-κB signaling pathway promoting the migration and invasion of ESCC cells.Combination of TNM staging and pathway based risk score models in patients with gastric cancer.Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
P2860
Q41911174-711B8A08-02A2-4186-86F6-A6866E3CE53BQ41999646-645A4F8F-565F-469E-A522-85D171EA6F9EQ47374256-A99382CE-4208-4BF6-A840-9F823093B59CQ47802781-0FE39D85-6771-4081-81CC-527F1B7C45C5Q48134310-15A7DD13-3DE9-4606-8D98-C12C37EA3D2FQ55021572-C81EF576-FAF9-456C-A573-7345D910E54DQ59133970-CC428854-415B-493A-9D4E-1D992D172CF6
P2860
Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Maraviroc decreases CCL8-mediated migration of CCR5
@nl
Maraviroc decreases CCL8-media ...... tic tumor growth in the lungs.
@en
type
label
Maraviroc decreases CCL8-mediated migration of CCR5
@nl
Maraviroc decreases CCL8-media ...... tic tumor growth in the lungs.
@en
prefLabel
Maraviroc decreases CCL8-mediated migration of CCR5
@nl
Maraviroc decreases CCL8-media ...... tic tumor growth in the lungs.
@en
P2093
P2860
P1433
P1476
Maraviroc decreases CCL8-media ...... tic tumor growth in the lungs.
@en
P2093
E C Halvorsen
J L Collier
K L Bennewith
M J Hamilton
N E LePard
P2860
P304
P356
10.1080/2162402X.2016.1150398
P577
2016-03-10T00:00:00Z